StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3050% below fair value
$2.56−0.16 (-5.88%)

Close on Nov 20, 2026Market cap $504.91MP/E –Yield –

Wave Life Sciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Wave Life Sciences's free cash flow for the twelve months ending Sep 30, 2026 was -$208.39M. For fiscal 2025 it was -$188.21M. The highest annual figure on record is -$3.60M in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$188.21M–
FY2024Dec 31, 2024-$151.96M–
FY2023Dec 31, 2023-$20.55M–
FY2022Dec 31, 2022-$129.14M–
FY2021Dec 31, 2021-$89.55M–
FY2020Dec 31, 2020-$117.32M–
FY2019Dec 31, 2019-$192.15M–
FY2018Dec 31, 2018-$32.80M–
FY2017Dec 31, 2017-$102.56M–
FY2016Dec 31, 2016-$37.49M–
FY2015Dec 31, 2015-$14.38M–
FY2014Dec 31, 2014-$5.02M–
FY2013Dec 31, 2013-$3.60M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$60.16M–
Q2 FY2026Jun 30, 2026-$54.47M–
Q1 FY2026Mar 31, 2026-$59.99M–
Q4 FY2025Dec 31, 2025-$33.78M–
Q3 FY2025Sep 30, 2025-$44.91M–
Q2 FY2025Jun 30, 2025-$46.32M–
Q1 FY2025Mar 31, 2025-$63.20M–
Q4 FY2024Dec 31, 2024-$43.73M–
Q3 FY2024Sep 30, 2024-$46.86M–
Q2 FY2024Jun 30, 2024-$27.52M–
Q1 FY2024Mar 31, 2024-$33.85M-139.8%
Q4 FY2023Dec 31, 2023-$33.60M–
Q3 FY2023Sep 30, 2023-$34.66M–
Q2 FY2023Jun 30, 2023-$37.33M–
Q1 FY2023Mar 31, 2023$85.03M–
Q4 FY2022Dec 31, 2022-$33.64M–
Q3 FY2022Sep 30, 2022-$26.10M–
Q2 FY2022Jun 30, 2022-$29.31M–
Q1 FY2022Mar 31, 2022-$40.08M–
Q4 FY2021Dec 31, 2021-$7.05M–
Q3 FY2021Sep 30, 2021-$28.28M–
Q2 FY2021Jun 30, 2021-$9.74M–
Q1 FY2021Mar 31, 2021-$44.48M–
Q4 FY2020Dec 31, 2020-$31.97M–
Q3 FY2020Sep 30, 2020-$20.24M–
Q2 FY2020Jun 30, 2020-$38.28M–
Q1 FY2020Mar 31, 2020-$26.83M–
Q4 FY2019Dec 31, 2019-$62.59M–
Q3 FY2019Sep 30, 2019-$44.15M–
Q2 FY2019Jun 30, 2019-$34.53M-149.7%
Q1 FY2019Mar 31, 2019-$50.89M–
Q4 FY2018Dec 31, 2018-$36.28M–
Q3 FY2018Sep 30, 2018-$32.40M–
Q2 FY2018Jun 30, 2018$69.47M–
Q1 FY2018Mar 31, 2018-$33.59M–
Q4 FY2017Dec 31, 2017-$26.83M–
Q3 FY2017Sep 30, 2017-$29.02M–
Q2 FY2017Jun 30, 2017-$25.66M–
Q1 FY2017Mar 31, 2017-$21.05M–
Q4 FY2016Dec 31, 2016-$16.08M–

More Wave Life Sciences figures

See a number that looks wrong?